Bharglob 16.5% Injection is a medication that helps boost the body's natural immune system to reduce the risk of infections in individuals with weakened immune systems. It is derived from healthy human blood containing high levels of antibodies, which are crucial for fighting infections. This injection has been found effective in preventing infections in bone marrow transplant patients over 20 years old within the first 100 days post-transplant. It is particularly beneficial for patients with impaired antibody-forming capacity, putting them at a higher risk of infections. The antibodies provided by Bharglob 16.5% Injection help the body combat infections that it may not be able to tackle on its own. This therapy is suitable for both children and adults and is administered through an injection under the supervision of a healthcare professional. Patients are closely monitored for any potential side effects following the administration.

In some cases, Bharglob 16.5% Injection may lead to side effects like injection site reactions such as swelling, redness, pain, itching, bruising, and rash, as well as flushing. Patients are advised to report any side effects or feelings of being unwell to their doctor. Prior to using this medication, it is essential to inform your doctor if you have any blood clotting issues or have had recent or planned vaccinations. The safety of Bharglob 16.5% Injection during pregnancy and breastfeeding is not entirely known, so it is recommended to seek advice from a healthcare provider.

Bharglob 16.5% Injection 1's falls under the category of immunising agents and is used to treat immunoglobulin deficiency and various inflammatory disorders. It is useful in managing primary immunodeficiency present from birth and secondary immunodeficiency developed later in life. Additionally, Bharglob 16.5% Injection 1's is employed in treating inflammatory conditions like primary immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. This medication contains Human normal immunoglobulin, which replaces deficient antibodies necessary for combating infections and inflammation. It functions similar to the body's natural immunoglobulins, aiding in immune response against foreign elements and reducing inflammation.

Bharglob 16.5% Injection 1's should only be administered by a trained healthcare professional to avoid potential side effects such as swelling at the injection site, headache, pain in various body parts, fever, flu-like symptoms, blisters in the mouth, and throat tightness. These side effects are usually mild and temporary, but persistent or worsening side effects should be promptly reported to a doctor. It is advised to avoid Bharglob 16.5% Injection 1's if allergic to any of its components or have blood clotting disorders. Patients should disclose recent vaccinations or previous use of this product to their healthcare provider. Caution should be exercised in individuals with immunoglobulin A deficiency, the elderly, and children, pregnant women, or breastfeeding mothers. Avoiding alcohol consumption while taking Bharglob 16.5% Injection 1's is recommended due to potential interactions. Additionally, this medication may cause dizziness, so activities like driving or operating heavy machinery should be avoided if experiencing dizziness.